To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

IL-1 Receptor Antagonist … - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Contact form


Note! If you want an answer on a question you must specify your email address

IL-1 Receptor Antagonist Treatment Aggravates Staphylococcal Septic Arthritis and Sepsis in Mice.

Journal article
Authors Abukar Ali
Manli Na
Mattias Svensson
Malin Magnusson
Amanda Welin
Jan-Christoph Schwarze
Majd Mohammad
Elisabet Josefsson
Rille Pullerits
Tao Jin
Published in PloS one
Volume 10
Issue 7
Pages e0131645
ISSN 1932-6203
Publication year 2015
Published at Institute of Medicine, Department of Rheumatology and Inflammation Research
Pages e0131645
Language en
Subject categories Immunobiology


Interleukin-1 receptor antagonist (IL-1Ra) is the primary therapy against autoinflammatory syndromes with robust efficacy in reducing systemic inflammation and associated organ injury. However, patients receiving IL-1Ra might be at increased risk of acquiring serious infections.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?